Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : The Trump Presidency -- Ignore unavailable to you. Want to Upgrade?

To: Lane3 who wrote (172299)	7/11/2020 6:22:50 PM
From: i-node	Read Replies (1) \| Respond to of 356081

>> HCQ will have definitive proof whenever the RCTs and the FDA say so. Until then, it's belief. First, you must understand that the "RCT" is not the end-all for medical research. Sometimes, it just doesn't work. I would expect you do realize this. Secondly, there are a couple of excellent recent studies, e.g., preprints.org that clearly support the immediate use of HCQ as opposed to just letting patients die without treatment, which is what is now being done. (Yes, Remdesivir is a good last ditch effort but the success rate is low and it is only applicable after the illness has been ignored until there is no alternative.) HCQ with Zink & Zpak have a high success rate and and very low cost. And the Henry Ford studies from a few weeks ago are pretty conclusive and should not continue to be disrespected by amateurs and those opposed on political grounds. It is time for Democrats to stop killing patients. They've killed far too many already.